RxAnte Receives $25M Growth Financing
RxAnte, a Washington, D.C-based pharmacy care management business company, received $25M in Growth financing.
Trinity Capital Inc. (NASDAQ: TRIN, TRINL), provided the facility. $15M was drawn under the facility, and RxAnte has the option to draw an additional $10M, subject to the conditions under the agreement.
The company intends to use the funds to expand its business reach, continuing its work with health plans to bring down the $528 billion annual cost of under-use, over-use, and misuse of prescription drugs.
Led by CEO Josh Benner, RxAnte is a provider of predictive analytics and targeted clinical programs that improve medication prescribing and adherence. A key component of its offering is its Mosaic Pharmacy Service, which provides value-based, in-home pharmacy services to medically complex and vulnerable seniors. Mosaic directly improves prescribing, adherence, and drug therapy outcomes for patients under our care with the objective of improving quality and lowering total cost of care.